<SEC-DOCUMENT>0001193125-23-035865.txt : 20230213
<SEC-HEADER>0001193125-23-035865.hdr.sgml : 20230213
<ACCEPTANCE-DATETIME>20230213162007
ACCESSION NUMBER:		0001193125-23-035865
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20230213
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230213
DATE AS OF CHANGE:		20230213

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Cytek Biosciences, Inc.
		CENTRAL INDEX KEY:			0001831915
		STANDARD INDUSTRIAL CLASSIFICATION:	LABORATORY ANALYTICAL INSTRUMENTS [3826]
		IRS NUMBER:				472547526
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40632
		FILM NUMBER:		23618783

	BUSINESS ADDRESS:	
		STREET 1:		47215 LAKEVIEW BOULEVARD
		CITY:			FREMONT
		STATE:			CA
		ZIP:			94538
		BUSINESS PHONE:		(877) 922-9835

	MAIL ADDRESS:	
		STREET 1:		47215 LAKEVIEW BOULEVARD
		CITY:			FREMONT
		STATE:			CA
		ZIP:			94538

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Cytek BioSciences, Inc.
		DATE OF NAME CHANGE:	20201110
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d446963d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ctkb="http://cytekbio.com/20230213" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2023-02-13_to_2023-02-13">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2023-02-13_to_2023-02-13">0001831915</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="ctkb-20230213.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="duration_2023-02-13_to_2023-02-13"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001831915</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-02-13</xbrli:startDate> <xbrli:endDate>2023-02-13</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2023-02-13_to_2023-02-13">8-K</ix:nonNumeric></span></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section&#160;13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported):</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2023-02-13_to_2023-02-13" format="ixt:datemonthdayyearen">February&#160;13, 2023</ix:nonNumeric></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="duration_2023-02-13_to_2023-02-13">Cytek Biosciences, Inc.</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2023-02-13_to_2023-02-13" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2023-02-13_to_2023-02-13">001-40632</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2023-02-13_to_2023-02-13">47-2547526</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or other jurisdiction</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(IRS Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr></table> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:50%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:48%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2023-02-13_to_2023-02-13">47215 Lakeview Boulevard</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2023-02-13_to_2023-02-13">Fremont</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2023-02-13_to_2023-02-13" format="ixt-sec:stateprovnameen">California</ix:nonNumeric></p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:bottom"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2023-02-13_to_2023-02-13">94538</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Address of principal executive offices)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Zip Code)</span></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s telephone number, including area code: <ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2023-02-13_to_2023-02-13">(877)</ix:nonNumeric> <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2023-02-13_to_2023-02-13">922-9835</ix:nonNumeric></span></p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former name or former address, if changed since last report.)</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2023-02-13_to_2023-02-13" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2023-02-13_to_2023-02-13" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2023-02-13_to_2023-02-13" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2023-02-13_to_2023-02-13" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2023-02-13_to_2023-02-13">Common Stock, par value $0.001 per share</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2023-02-13_to_2023-02-13">CTKB</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2023-02-13_to_2023-02-13" format="ixt-sec:exchnameen">Nasdaq Global Select Market</ix:nonNumeric></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (&#167; 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167; 240.12b-2 of this chapter).</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company&#160;&#160;<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2023-02-13_to_2023-02-13" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#160;&#160;&#9744;</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;1.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Entry into a Material Definitive Agreement </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On February&#160;13, 2023, Cytek Biosciences, Inc. (the &#8220;Company&#8221;) entered into an Asset Purchase Agreement (the &#8220;Purchase Agreement&#8221;) with Luminex Corporation (&#8220;Luminex&#8221;), pursuant to which the Company agreed to acquire certain assets relating to the business of manufacturing, marketing, selling, servicing and maintaining Amnis-, CellStream-, Guava- and Muse-branded instruments, and flow cytometry reagent products and services of Luminex (the &#8220;Business&#8221;) for a purchase price of approximately $46.5&#160;million in cash. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Purchase Agreement contains customary representations, warranties and covenants of a transaction of this type. In connection with its entry into the Purchase Agreement, the Company has purchased a customary representations and warranties insurance policy as recourse for certain losses arising out of a breach of the representations and warranties of Luminex contained in the Purchase Agreement. The representations and warranties insurance policy is subject to certain policy limits, exclusions, deductibles and other terms and conditions. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Purchase Agreement includes an agreement for Luminex to provide certain transition services and to manufacture and supply certain components, materials and finished products relating to the Business for a period of up to six months following closing. The Company has also agreed to extend employment offers to certain Luminex U.S. and <span style="white-space:nowrap">non-U.S.</span> employees in connection with the transaction. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Purchase Agreement provides for the closing of the transaction within three business days after satisfaction or waiver of closing conditions, but in no event earlier than February&#160;28, 2023. Subject to the satisfaction of customary closing conditions set forth in the Purchase Agreement, the Company expects the transaction to close within thirty days. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The foregoing summary of the Purchase Agreement does not purport to be complete and is qualified in its entirety by reference to the complete terms of the Purchase Agreement, a copy of which will be filed with the Company&#8217;s Annual Report on Form <span style="white-space:nowrap">10-K</span> for the year ended December&#160;31, 2022. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;7.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Regulation FD Disclosure </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On February&#160;13, 2023, the Company issued a press release (the &#8220;Press Release&#8221;) announcing the Company&#8217;s entry into the Purchase Agreement. A copy of the Press Release is furnished as Exhibit 99.1 to this Form <span style="white-space:nowrap">8-K</span> and is incorporated herein by reference. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The information in this Item 7.01 of the Form <span style="white-space:nowrap">8-K,</span> including Exhibit 99.1, is furnished and shall not be deemed &#8220;filed&#8221; for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference in any filing made by the Company under the&#160;Securities Act of 1933, as amended, whether made before or after the date hereof, regardless of any general incorporation language in such filing. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Forward-Looking Statements </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Press Release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 as contained in Section&#160;27A of the Securities Act of 1933, as amended, and Section&#160;21E of the Securities Exchange Act of 1934, as amended, which are subject to the &#8220;safe harbor&#8221; created by those sections. All statements, other than statements of historical facts, may be forward-looking statements. Forward-looking statements generally can be identified by the use of forward-looking terminology such as &#8220;may,&#8221; &#8220;might,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;expect,&#8221; &#8220;plan,&#8221; &#8220;anticipate,&#8221; &#8220;could,&#8221; &#8220;intend,&#8221; &#8220;target,&#8221; &#8220;project,&#8221; &#8220;contemplate,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; &#8220;predict,&#8221; &#8220;potential&#8221; or &#8220;continue&#8221; or the negatives of these terms or variations of them or similar terminology, but the absence of these words does not mean that a statement is not forward-looking. These forward-looking statements include statements regarding the Company&#8217;s acquisition of the Business, the timing of the closing of the transaction, the expected benefits of the transaction, the integration of the Business and employees into the Company, the Company&#8217;s future solutions offerings and product strategy. These statements are based on management&#8217;s current expectations, forecasts, beliefs, assumptions and information currently available to management. These statements also deal with future events and involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from the information expressed or implied by these forward-looking statements. Factors that could cause actual results to differ materially include risks and uncertainties such as, among others, the possibility that the transaction will not close or that the closing may be delayed or that we will not achieve the anticipated benefits from the transaction or accomplish its stated goals. You should refer to the section entitled &#8220;Risk Factors&#8221; set forth in </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the Company&#8217;s Quarterly Report on Form <span style="white-space:nowrap">10-Q</span> filed with the SEC on November&#160;9, 2022, the Company&#8217;s Annual Report on Form <span style="white-space:nowrap">10-K</span> to be filed with the SEC and other filings the Company makes with the SEC from time to time for a discussion of important factors that may cause actual results to differ materially from those expressed or implied by the Company&#8217;s forward-looking statements. Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, it cannot provide any assurance that these expectations will prove to be correct nor can it guarantee that the future results, levels of activity, performance and events and circumstances reflected in the forward-looking statements will be achieved or occur. The forward-looking statements in this press release are based on information available to the Company as of the date hereof, and the Company disclaims any obligation to update any forward-looking statements provided to reflect any change in its expectations or any change in events, conditions, or circumstances on which any such statement is based, except as required by law. These forward-looking statements should not be relied upon as representing the Company&#8217;s views as of any date subsequent to the date of this press release. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;9.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">(d) Exhibits </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td></td>

<td style="vertical-align:bottom;width:5%"></td>
<td style="width:92%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Exhibit</p> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">&#160;&#160;&#160;&#160;No.&#160;&#160;&#160;&#160;</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman;font-weight:bold">Description</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d446963dex991.htm">Press Release dated February&#160;13, 2023</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL document)</td></tr>
</table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">SIGNATURES </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:45%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:4%"></td>

<td style="vertical-align:bottom"></td>
<td style="width:3%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:45%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="3"><span style="font-weight:bold">Cytek Biosciences, Inc.</span></td></tr>


<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">Date: February&#160;13, 2023</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&#160;&#160;&#160;&#160;/s/ Wenbin Jiang, Ph.D.</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#160;&#160;&#160;&#160;Wenbin Jiang, Ph.D.</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">&#160;&#160;&#160;&#160;President and Chief Executive Officer</p></td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d446963dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">


<IMG SRC="g446963dsp5.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="right">


<IMG SRC="g446963dsp5a.jpg" ALT="LOGO">
</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>C<SMALL>YTEK<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP></SMALL> B<SMALL>IOSCIENCES</SMALL> <SMALL>TO</SMALL>
A<SMALL>CQUIRE</SMALL> F<SMALL>LOW</SMALL> C<SMALL>YTOMETRY</SMALL> <SMALL>AND</SMALL> I<SMALL>MAGING</SMALL> B<SMALL>USINESS</SMALL> <SMALL>FROM</SMALL> D<SMALL>IA</SMALL>S<SMALL>ORIN</SMALL> </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">S<SMALL>ALE</SMALL> <SMALL>OF</SMALL> <SMALL>ASSETS</SMALL> <SMALL>RELATED</SMALL> <SMALL>TO</SMALL>
F<SMALL>LOW</SMALL> C<SMALL>YTOMETRY</SMALL>&nbsp;&amp; I<SMALL>MAGING</SMALL> (FCI) B<SMALL>USINESS</SMALL> U<SMALL>NIT</SMALL> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">A<SMALL>CQUISITION</SMALL> <SMALL>WILL</SMALL> <SMALL>EXPAND</SMALL> C<SMALL>YTEK</SMALL>&#146;<SMALL>S</SMALL>
<SMALL>PRODUCT</SMALL> <SMALL>PORTFOLIO</SMALL> <SMALL>TO</SMALL> <SMALL>INCLUDE</SMALL> <SMALL>IMAGING</SMALL> <SMALL>AND</SMALL> <SMALL>MENU</SMALL>-<SMALL>BASED</SMALL> <SMALL>APPLICATION</SMALL> <SMALL>DRIVEN</SMALL> <SMALL>FLOW</SMALL>
<SMALL>CYTOMETRY</SMALL> <SMALL>TO</SMALL> <SMALL>PROVIDE</SMALL> <SMALL>FULL</SMALL> <SMALL>CELL</SMALL> <SMALL>ANALYSIS</SMALL> <SMALL>SOLUTIONS</SMALL> <SMALL>TO</SMALL> <SMALL>ITS</SMALL> <SMALL>CUSTOMERS</SMALL> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><SMALL>TRANSACTION</SMALL> <SMALL>IS</SMALL> <SMALL>IN</SMALL> <SMALL>LINE</SMALL> <SMALL>WITH</SMALL>
D<SMALL>IA</SMALL>S<SMALL>ORIN</SMALL>&#146;<SMALL>S</SMALL> <SMALL>STRATEGIC</SMALL> <SMALL>PRIORITIES</SMALL> <SMALL>COMMUNICATED</SMALL> <SMALL>TO</SMALL> <SMALL>THE</SMALL> <SMALL>MARKET</SMALL> <SMALL>AFTER</SMALL> L<SMALL>UMINEX</SMALL>
<SMALL>ACQUISITION</SMALL> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">E<SMALL>MPLOYEES</SMALL> <SMALL>ASSOCIATED</SMALL> <SMALL>WITH</SMALL> <SMALL>COMMERCIAL</SMALL>,
<SMALL>OPERATIONS</SMALL>, R&amp;D <SMALL>AND</SMALL> <SMALL>SUPPORTING</SMALL> <SMALL>FUNCTIONS</SMALL> <SMALL>EXPECTED</SMALL> <SMALL>TO</SMALL> <SMALL>JOIN</SMALL> C<SMALL>YTEK</SMALL> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I></I><B><I>SALUGGIA (Italy),</I></B><I></I><B><I></I></B><I></I><B><I>&nbsp;and FREMONT, California (USA),
February</I></B><I></I><B><I></I></B><I></I><B><I>&nbsp;13, 2023</I></B><I></I><B><I></I></B><I>&nbsp;&#150; <U>DiaSorin</U> (FTSE MIB: DIA) and <U>Cytek Biosciences, Inc</U>. (Nasdaq: CTKB) today announced&nbsp;that Luminex Corporation, a wholly
owned subsidiary of DiaSorin, has signed an agreement with Cytek to sell substantially all of its assets related to the Flow Cytometry&nbsp;&amp; Imaging (FCI) business unit. The sale is expected to close within 30 days, subject to customary closing
conditions. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>The FCI business unit, acquired by Luminex in October 2018, is based on both conventional flow cytometry and image-based flow
cytometry instrumentation, which provide insights into all facets of cellular phenotypes and morphology. The FCI business unit includes dedicated commercial, operations, R&amp;D, and supporting personnel. </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>An existing installed base of more than 7,000 instruments will be under the Cytek umbrella following the acquisition, expanding the company&#146;s global
commercial footprint. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>The decision to sell the FCI business unit to Cytek is in line with the strategic priorities communicated to investors
during the Capital Market Day in December 2021. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>&#147;We are currently working on several projects that will allow DiaSorin to further growth and
strengthen our positioning as a specialty player over the next years,&#148; commented Angelo Rago, president of Luminex. &#147;To do so, we need to be extremely focused on the core for our future and, therefore, we decided to sell the Flow
Cytometry&nbsp;&amp; Imaging business unit to a dedicated, leading player in the space. We are convinced that Cytek will be able to grow it with success in the future.&#148; </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Over 60% of employees supporting the FCI business unit are within the commercial organization, including sales and marketing personnel, technical
application scientists and field service engineers. These additions will greatly enhance Cytek&#146;s ability to grow sales and service customers by expanding Cytek&#146;s reach and its offerings into customer segments previously underserved. The
majority of the commercial employees are located in EMEA, China and APAC. These additions will further strengthen Cytek teams in those geographies. </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>By adding <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">first-to-market</FONT></FONT> Amnis<SUP
STYLE="font-size:75%; vertical-align:top">&reg;</SUP> imaging flow cytometers to its robust lineup of cell analysis solutions, Cytek will be able to provide researchers and scientists with tools that combine high-resolution cell images with the
speed, sensitivity and phenotyping abilities of flow cytometry. The addition of Guava<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> flow cytometers will expand Cytek&#146;s core instrument offerings, adding cost-effective, entry-level
and personal instrument options to broaden the market and research areas it services. </I></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">


<IMG SRC="g446963dsp5.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">


<IMG SRC="g446963dsp5a.jpg" ALT="LOGO">
</TD></TR></TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>&#147;The talent and technology that come along with this acquisition will bolster our offerings to
address the current market and further our mission to provide a complete cell analysis solution to our customers,&#148; noted Wenbin Jiang, CEO of Cytek Biosciences. &#147;We look forward to welcoming Luminex&#146;s flow cytometry team into our own
and working together to serve our customers and to move cellular research forward.&#148; </I></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Cytek Biosciences, Inc. Investor Conference Call
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Cytek will host a conference call on&nbsp;Monday, February&nbsp;13, 2023,&nbsp;at 1:30 PM Pacific Time / 4:30 PM Eastern Time. A webcast of the
conference call can be accessed at <U>investors.cytekbio.com</U>. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About DiaSorin </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Headquartered in Italy and listed at the Italian Stock Exchange in the FTSE MIB Index, DiaSorin is a global leader in the In Vitro Diagnostic (IVD) field
and is active since 2021 in the Life Science business. For over 50 years, the Company has been developing, producing and marketing reagent kits used by diagnostic laboratories worldwide. </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>The Group operates in 5 continents through 43 companies, 4 branches, 10 manufacturing facilities and 9 research and development centers. The extensive
diagnostic testing and Life Science offer, made available through continuous investments in research, positions DiaSorin as the player with the broadest range of specialty tests available within the diagnostic market, and identifies the Group as the
&#147;Diagnostic Specialist.&#148; </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>More info at <U>www.diasoringroup.com</U> </I></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Cytek Biosciences, Inc. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Cytek Biosciences (Nasdaq:
CTKB) is a leading cell analysis solutions company advancing the next generation of cell analysis tools by delivering high-resolution, high-content and high-sensitivity cell analysis utilizing its patented Full Spectrum Profiling<SUP
STYLE="font-size:75%; vertical-align:top">&#153;</SUP> (FSP<SUP STYLE="font-size:75%; vertical-align:top">&#153;</SUP>) technology. Cytek&#146;s novel approach harnesses the power of information within the entire spectrum of a fluorescent signal to
achieve a higher level of multiplexing with precision and sensitivity. Cytek&#146;s FSP platform includes its core instruments, the Aurora and Northern Lights<SUP STYLE="font-size:75%; vertical-align:top">&#153;</SUP> systems; its cell sorter, the
Aurora CS; and reagents, software and services to provide a comprehensive and integrated suite of solutions for its customers. Cytek is headquartered in Fremont, California with offices and distribution channels across the globe. More information
about the company and its products is available at <U>www.cytekbio.com</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Other than Cytek&#146;s Northern Lights CLC system and certain reagents for
use therewith, which are available for clinical use in countries where the regulatory approval has been obtained from the local regulatory authorities, including China and the European Union, Cytek&#146;s products are for research use only and not
for use in diagnostic procedures. Please contact your local sales representatives for the status of local regulatory approval. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Cytek, cFluor, Full
Spectrum Profiling, FSP and Northern Lights are trademarks or registered trademarks of Cytek Biosciences, Inc. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition to filings with the Securities
and Exchange Commission (SEC), press releases, public conference calls and webcasts, Cytek uses its website (<U>www.cytekbio.com</U>), <U>LinkedIn page</U>, <U>YouTube channel</U>, and <U>corporate Twitter account</U> as channels of distribution of
information about its company, products, planned financial and other announcements, attendance at upcoming investor and industry conferences and other matters. Such information may be deemed material information and Cytek may use these channels to
comply with its disclosure obligations under Regulation FD. Therefore, investors should monitor Cytek&#146;s website, LinkedIn page, and Twitter account in addition to following its SEC filings, news releases, public conference calls and webcasts.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward-Looking Statements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This press release
contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 as contained in Section&nbsp;27A of the Securities Act of 1933, as amended, and Section&nbsp;21E of the Securities Exchange Act of 1934,
as amended, which are subject to the &#147;safe harbor&#148; created by those sections. All statements, other than statements of historical facts, may be forward-looking statements. Forward-looking statements generally can be identified by the use
of forward-looking terminology such as &#147;may,&#148; &#147;might,&#148; &#147;will,&#148; &#147;should,&#148; &#147;expect,&#148; &#147;plan,&#148; &#147;anticipate,&#148; &#147;could,&#148; &#147;intend,&#148; &#147;target,&#148;
&#147;project,&#148; &#147;contemplate,&#148; &#147;believe,&#148; &#147;estimate,&#148; &#147;predict,&#148; &#147;potential&#148; or &#147;continue&#148; or the negatives of these terms or variations of them or similar terminology, but the absence
of these words does not mean that a statement is not forward-looking. These forward-looking statements include statements regarding Cytek&#146;s acquisition of the Flow Cytometry&nbsp;&amp; Imaging (FCI) business unit of Luminex, the timing of the
closing of the transaction, the expected benefits of the transaction, the integration of the FCI business and employees into Cytek, and Cytek&#146;s future solutions offerings and product strategy. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">


<IMG SRC="g446963dsp5.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">


<IMG SRC="g446963dsp5a.jpg" ALT="LOGO">
</TD></TR></TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
These statements are based on management&#146;s current expectations, forecasts, beliefs, assumptions and information currently available to management. These statements also deal with future
events and involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from the information expressed or implied by these forward-looking statements. Factors
that could cause actual results to differ materially include risks and uncertainties such as those relating to the inability to timely complete or complete at all the transaction because of the failure to satisfy conditions to closing; the risk that
the transaction disrupts Cytek&#146;s current plans and operations or diverts management&#146;s attention from its ongoing business; Cytek&#146;s ability to integrate the operations and employees of the FCI business; Cytek&#146;s ability to
recognize the anticipated benefits of the transaction; Cytek&#146;s ability to manage the growth and complexity of its organization, maintain relationships with customers and suppliers and retain key employees; and uncertainties relating to market
conditions. You should refer to the section entitled &#147;Risk Factors&#148; set forth in Cytek Biosciences&#146; Quarterly Report <FONT STYLE="white-space:nowrap">on&nbsp;Form&nbsp;10-Q</FONT> filed with the SEC on November&nbsp;9, 2022 and other
filings Cytek Biosciences makes with the SEC from time to time for a discussion of important factors that may cause actual results to differ materially from those expressed or implied by Cytek Biosciences&#146; forward-looking statements. Although
Cytek Biosciences believes that the expectations reflected in the forward-looking statements are reasonable, it cannot provide any assurance that these expectations will prove to be correct nor can it guarantee that the future results, levels of
activity, performance and events and circumstances reflected in the forward-looking statements will be achieved or occur. The forward-looking statements in this press release are based on information available to Cytek Biosciences as of the date
hereof, and Cytek Biosciences disclaims any obligation to update any forward-looking statements provided to reflect any change in its expectations or any change in events, conditions, or circumstances on which any such statement is based, except as
required by law. These forward-looking statements should not be relied upon as representing Cytek Biosciences&#146; views as of any date subsequent to the date of this press release. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>D<SMALL>IA</SMALL>S<SMALL>ORIN</SMALL> C<SMALL>ONTACTS</SMALL></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>I<SMALL>NVESTOR</SMALL> R<SMALL>ELATIONS</SMALL> </B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Riccardo Fava</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><B>Eugenia Ragazzo</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><I>Corporate Vice President Communication&nbsp;&amp; Investor Relations</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><I>Corporate Investor Relations&nbsp;&amp; ESG Analyst</I></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><U>riccardo.fava@diasorin.it</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><U>eugenia.ragazzo@diasorin.it</U></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>C<SMALL>YTEK</SMALL> C<SMALL>ONTACTS</SMALL></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>M<SMALL>EDIA</SMALL> R<SMALL>ELATIONS</SMALL> </B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><B>I<SMALL>NVESTOR</SMALL> R<SMALL>ELATIONS</SMALL></B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Stephanie Olsen</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><B>Paul Goodson</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Lages&nbsp;&amp; Associates</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Head of Investor Relations</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">(949) <FONT STYLE="white-space:nowrap">453-8080</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Cytek Biosciences</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><U>stephanie@lages.com</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><U>pgoodson@cytekbio.com</U></TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>ctkb-20230213.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 2/14/2023 1:50:06 AM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2022"
  xmlns:ctkb="http://cytekbio.com/20230213"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://cytekbio.com/20230213"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" namespace="http://xbrl.sec.gov/dei/2022" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2022/naics-2022.xsd" namespace="http://xbrl.sec.gov/naics/2022" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ctkb-20230213_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ctkb-20230213_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://cytekbio.com//20230213/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>ctkb-20230213_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 2/14/2023 1:50:06 AM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>ctkb-20230213_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 2/14/2023 1:50:06 AM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://cytekbio.com//20230213/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="ctkb-20230213.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://cytekbio.com//20230213/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="25.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g446963dsp5.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g446963dsp5.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M+GZR% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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MNY55I5N+\PK4*D:M&IAVXRBTXO\ @7LUV=T?K[7YP?>A0 4 % !0 4 % !0
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MLGRITW;77)VLI&>* )Z "@#\9_\ @KE_J/@3_P!=_B%_Z*\(U^G>&W\;-O\
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M/^'2G@O_ *+-XL_\);1?_EA1_P 1(QO_ $+J/_@=3_(/]1,)_P!!E7_P6O\
MY(/^'2G@O_HLWBS_ ,);1?\ Y84?\1(QO_0NH_\ @=3_ "#_ %$PG_095_\
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
; H * "@ H * "@ H * "@ H * "@ H * /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g446963dsp5a.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g446963dsp5a.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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MTBTU9VLG=.UT[_FO&&69?1G'&9;"-**:C6C35J;D[VE!+1;)2Y;1;::UO?\
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M [:/>@ VCWH -H]Z #:/>@ VCWH -H]Z #:/>@ VCWH -H]Z #:/>@ VCWH
M-H]Z #:/>@ VCWH -H]Z #:/>@ VCWH -H]Z #:/>@ VCWH -H]Z #:/>@ V
MCWH -H]Z #:/>@ VC\OTQ0!SGAWQ?X0\7C5&\)>*O#GBA="U2YT/6V\.ZYIF
MMC1]:LL?:]'U0Z9<S#3]4@W+YEI/Y<L>X;D&: .CVCWH -H]Z '4 % !0 4
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MQ7>L^LZ=H6I6GAW4UMKRUO1? 'Z>T % !0 4 % !0 4 % !0 4 % !0 4 %
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M_P ,R^*?^BT:W_X([S_YK:_'_P#B!&>?]'/S#_PEQ7_SY/TW_B,&4?\ 1O\
M!?\ A1A__G6'_#,OBG_HM&M_^".\_P#FMH_X@1GG_1S\P_\ "7%?_/D/^(P9
M1_T;_!?^%&'_ /G6'_#,OBG_ *+1K?\ X([S_P":VC_B!&>?]'/S#_PEQ7_S
MY#_B,&4?]&_P7_A1A_\ YUA_PS+XI_Z+1K?_ (([S_YK:/\ B!&>?]'/S#_P
MEQ7_ ,^0_P"(P91_T;_!?^%&'_\ G6'_  S+XI_Z+1K?_@CO/_FMH_X@1GG_
M $<_,/\ PEQ7_P ^0_XC!E'_ $;_  7_ (48?_YUA_PS+XI_Z+1K?_@CO/\
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M%?\ SY#_ (C!E'_1O\%_X48?_P"=8?\ #,OBG_HM&M_^".\_^:VC_B!&>?\
M1S\P_P#"7%?_ #Y#_B,&4?\ 1O\ !?\ A1A__G6'_#,OBG_HM&M_^".\_P#F
MMH_X@1GG_1S\P_\ "7%?_/D/^(P91_T;_!?^%&'_ /G6'_#,OBG_ *+1K?\
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MM_\ @CO/_FMH_P"($9Y_T<_,/_"7%?\ SY#_ (C!E'_1O\%_X48?_P"=8?\
M#,OBG_HM&M_^".\_^:VC_B!&>?\ 1S\P_P#"7%?_ #Y#_B,&4?\ 1O\ !?\
MA1A__G6*O[,WBE64_P#"Z-<^4@\:)>*>#V/_  EIP??%"\",\5O^-GYBK?\
M4-BO_GSH'_$8,H_Z-_@O_"C#_P#SK/JK2K*33=+TW3I;RXU"6PL+.REU"[(:
M[OI+6WC@>\NF'!N)FC,CG^\YK^A,OPL\%@,#@JF)J8RIA,/1HRQ%9WJUY4J<
M:<JU5K>I5<7.;_FDS\5QF(CBL9B\53H0PD,16JU8T:2M3HQJ3E-4J:Z0II\D
)%TBD7ZZSF/_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139837368504816">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Feb. 13, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001831915<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Feb. 13,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Cytek Biosciences, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-40632<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">47-2547526<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">47215 Lakeview Boulevard<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Fremont<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94538<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(877)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">922-9835<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CTKB<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>d446963d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="ctkb-20230213.xsd" xlink:type="simple"/>
    <context id="duration_2023-02-13_to_2023-02-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001831915</identifier>
        </entity>
        <period>
            <startDate>2023-02-13</startDate>
            <endDate>2023-02-13</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="duration_2023-02-13_to_2023-02-13">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2023-02-13_to_2023-02-13"
      id="Hidden_dei_EntityCentralIndexKey">0001831915</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2023-02-13_to_2023-02-13">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2023-02-13_to_2023-02-13">2023-02-13</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2023-02-13_to_2023-02-13">Cytek Biosciences, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2023-02-13_to_2023-02-13">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2023-02-13_to_2023-02-13">001-40632</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2023-02-13_to_2023-02-13">47-2547526</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2023-02-13_to_2023-02-13">47215 Lakeview Boulevard</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2023-02-13_to_2023-02-13">Fremont</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2023-02-13_to_2023-02-13">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2023-02-13_to_2023-02-13">94538</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2023-02-13_to_2023-02-13">(877)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2023-02-13_to_2023-02-13">922-9835</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2023-02-13_to_2023-02-13">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2023-02-13_to_2023-02-13">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2023-02-13_to_2023-02-13">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2023-02-13_to_2023-02-13">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2023-02-13_to_2023-02-13">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2023-02-13_to_2023-02-13">CTKB</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2023-02-13_to_2023-02-13">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2023-02-13_to_2023-02-13">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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MKW#.RW^0\Y^M<\TUMTQ>DO:C_S=7^2V,D_'T7!S1JP,Z6PE<A!OZ%>Y7>>9
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M)$WS/(X %F>0IA@"IQ%', ;  4/2='@//GL?)=-[*CG_5U/\!%!+ P04
M" ""@DU6EXJ[',     3 @  "P   %]R96QS+RYR96QSG9*Y;L,P#$!_Q=">
M, ?0(8@S9?$6!/D!5J(/V!(%BD6=OZ_:I7&0"QEY/3P2W!YI0.TXI+:+J1C]
M$%)I6M6X 4BV)8]ISI%"KM0L'C6'TD!$VV-#L%HL/D N&6:WO606IW.D5XA<
MUYVE/=LO3T%O@*\Z3'%":4A+,P[PS=)_,O?S##5%Y4HCE5L:>-/E_G;@2=&A
M(E@6FD7)TZ(=I7\=Q_:0T^FO8R*T>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X
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M%_\;SO$1PNZ_/[&\UDX:?^:+X3]>?P%02P$"% ,4    " ""@DU6!T%-8H$
M  "Q    $               @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4
M Q0    ( (*"359,C@I-[0   "L"   1              "  :\   !D;V-0
M<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( (*"35:97)PC$ 8  )PG   3
M          "  <L!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @
M@H)-5I[NOZ)2!   EA   !@              ("!# @  'AL+W=O<FMS:&5E
M=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( (*"35:?H!OPL0(  .(,   -
M          "  90,  !X;"]S='EL97,N>&UL4$L! A0#%     @ @H)-5I>*
MNQS     $P(   L              ( !< \  %]R96QS+RYR96QS4$L! A0#
M%     @ @H)-5APX9>H_ 0  / (   \              ( !61   'AL+W=O
M<FMB;V]K+GAM;%!+ 0(4 Q0    ( (*"358D'INBK0   /@!   :
M      "  <41  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0
M   ( (*"359ED'F2&0$  ,\#   3              "  :H2  !;0V]N=&5N
B=%]4>7!E<UTN>&UL4$L%!@     )  D /@(  /03      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d446963d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cytekbio.com//20230213/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="d446963d8k.htm">d446963d8k.htm</File>
    <File>ctkb-20230213.xsd</File>
    <File>ctkb-20230213_lab.xml</File>
    <File>ctkb-20230213_pre.xml</File>
    <File>d446963dex991.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "d446963d8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2022": 22
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "d446963d8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "ctkb-20230213_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ctkb-20230213_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "ctkb-20230213.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/naics/2022/naics-2022.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "ctkb",
   "nsuri": "http://cytekbio.com/20230213",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d446963d8k.htm",
      "contextRef": "duration_2023-02-13_to_2023-02-13",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://cytekbio.com//20230213/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d446963d8k.htm",
      "contextRef": "duration_2023-02-13_to_2023-02-13",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cytekbio.com//20230213/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cytekbio.com//20230213/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cytekbio.com//20230213/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cytekbio.com//20230213/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cytekbio.com//20230213/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cytekbio.com//20230213/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cytekbio.com//20230213/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cytekbio.com//20230213/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cytekbio.com//20230213/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cytekbio.com//20230213/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cytekbio.com//20230213/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cytekbio.com//20230213/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cytekbio.com//20230213/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cytekbio.com//20230213/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cytekbio.com//20230213/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cytekbio.com//20230213/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cytekbio.com//20230213/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cytekbio.com//20230213/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cytekbio.com//20230213/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cytekbio.com//20230213/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cytekbio.com//20230213/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cytekbio.com//20230213/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001193125-23-035865-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-23-035865-xbrl.zip
M4$L#!!0    ( (*"35:PDZE"/0,  $ +   1    8W1K8BTR,#(S,#(Q,RYX
M<V2]5EU/VS 4?9_$?[C+TR8M<=(.-"+*Q,:0D(!-A4U[0ZYS6RP<.[,=H/]^
MMI.4T$+7P;2^U/4]Y_K<#U]W[^-=*> &M>%*CJ(L22- R53!Y6P4U2:FAG$>
M?=S?>K7W.H[A\.CX#&*XLK8R.2&WM[=),>72*%%;Y\$D3)4$XKC#?[[X#C\:
M[SF,42 U""4U%C5\JKDH\D$Z&&19^B'9Z=,T4N\/"FHQAP')WA,''$*6;Z=Y
MN@,'I_ E>)%PP4OL4U4UUWQV9>$->PN!=*BD1"%P#D=<4LDX%7#>*7X'QY(E
M<" $C#W-.)D&]0T62>OUSA2Y85=8TJU7 "Y?TN32N:S+4>03T>;A;J)%HO2,
M%%83.Z^0.%#L4*@YBWK4/_-6.*X0WF(6Q"DUDT#J+#X]@QZ#V>O) LWF%J\G
M7(7J^)2D@VS8 Q?(%]@@QR!+9NJ&.,.R8V_GCP<P2-,A<<U@78ZQ1Q%<7J]A
M>//$]47_D!7*[3 0LMW=71*L2Y(*^S""UOLV:8P!3:W5?%);/%*Z/,0IK85C
MU?)7306?<BP"RC5IB=(^P#Q$6*IG:,]HB::B##=.LVNDQV)R,C/R\_3D//18
MM.\) *'M>%DI;:'IOA/%PJ58DTK_*^XJ$/NM.!O$PRQQSB*0*XK7E _(BX5T
MA7V6D$57;"S$/-6]?A'[Q5.G/][SS\[ \D7V\>_Z^+.=C>)?&03_0(F29R\5
MTYMFSZ^)I)PUPZI9;EZ7>^:+>K.;"#X/VVL/7AXA[:GA3"JELN&@OA):55Q.
M5;OE-GT3YUTGCW$*873E5#.M!*X?<*32JD)MN1ON]Y>A<7"E<3J*_(R/NSES
M*>@D<7.F@ZP<\/!Z>3-Q%!0G]_(ZKN76DT^\&;S=O9)4+%S[=AA%QN5=]*[G
M?PZWTOBWX3J*<9,]E.WIJ+_U4'\=O#_GPB' +[Z/CQ]_&Q:/ ['T3DE5SAN!
MAXK5_NWIO@]D\44Z6?-CUU6Z#)(BX.X5&3OXY4;PA<!.8H'N#QL/K9NE_N/^
MSW4>^DLJ"VC<0<_?'EEVLNR_-EA\E?MAS:A@M5@DO"6WB'7$Y5)MSKQ7]C2O
MW>V*U5UALGR'VYW^76^VFEGC?OX&4$L#!!0    ( (*"35808L[07 8  +Y#
M   5    8W1K8BTR,#(S,#(Q,U]L86(N>&ULS9QO;]LV$,;?%^AWN'EO-J"R
M8V<K%J-ID3E)$2QM@L3=A@U#(4N,34PB#5).[&\_4G\:.:9D*CQ->=%6D>Z>
MNT?^G4K+<MY]6,<1W!,A*6?'O6'_H >$!3RD;'[<6TG/EP&E/9")ST(_XHP<
M]S9$]CZ\?_WJW7>>!Z?G%Y_!@T62+.5X,'AX>.B'=Y1)'JT2)2G[ 8\'X'E%
M_&3Z!7[/RHWAAD3$EP1B7R9$P*\K&H7CT<%H-!P>_-)_6TX3Q-=Z$/H)&<-H
M,/QIH (/83C^^6!\\!9./L%9JL)@2F-23N7+C:#S10(_!#]"FG3*&2-11#9P
M3IG/ NI'<%MT_ 8N6-"'DRB"&YTF59N2B'L2]G/5B+)_Q_JOF6X>7K\"4&>1
MR73?<4^?B_Q4K&<BZG,Q5[T>' Z*E-YCQGHGY>$P31@>'1T-TJ/E:$E-L4I\
M./CST^5ML""Q[ZFSKUZM("\CZ5BF^R]YD)Y"BP:A,D+_Y!5AGM[E#4?>X;"_
MEF'OO2Z8GQU_1J)+M06IA['@$:DIK ^GU7MY?+)9JGBR3@@+2:[\39L'>=1"
MD+M,5;.72DH2].?\?A 2J@$9Z0U/;^@.OU<_?)UPA?O)3";"#Y+M>I$^15P4
M.U,3QSU#TF"[(1UW(H(M+5\$A8[:W.,_CQ@$7+UNR\1+%8OT.\%C8Q=Y.6XX
M^#6:1<8V-4EJ2T\W8=Z7VWU>,Z&R,4$D7PF%5Y.7-O7S/E6&OPOM?]X-'FN_
ME%;5)422RZ;]NB%Y$BO,U9_D//+GMD@^2>H(27/KW'#0!4F#$!*2WY1!2SL#
MV4*C92!MNW7#\8PE--E,5!GA1Q?J KS^C6QLL:Q([@C/>BN\)L@%UQI!)&RS
M"I"7@+0&J"+. +?8>AGDYOV[(7W*@Y6>FZGJWI;D[9R. #8VSG>/N>"ZJX-$
M:2$,6MD93?PVRT1:]HJ#X341E(=G+#Q5;V>:\O@DN6,PS59X31 &J@9!;&:S
M$J!J@"Z"AF\+K1LYMNX?8[%P0^94+Y)9\MF/K8DVYW:Z5*@PPJMCW!<*)CW<
M=<)C!= ED%8);?1M6"18-X\!\@4+N%ARD=XJN4W4X$SX2BU2-A,>-N1ZCU2G
MF-O9Y-8I[D-@(8\[$UL%(:T(>4G0-9&&Y'_P99B9YYO#&*)S&I'/JWA&1+.)
M*>=U.AX& ]Q\W!W\IUJXE&MUR.21@,;NUT"O5=,8H$[]]46H%DOTCF8WQY]#
M;:5(IPCOL\8M@MWAKA7&)5V5@NU:N-RW:L4P!,_P@S$2)V&H#,C\GTO*R+#9
M.!@%.AV%.DM\3Z#["%2*XN*?Z[\I-D!7@BN&M8YIS88!_6=X041_HC:OQ)0_
ML&>!7TY_"=@;[)B@?PQ#0_ZI9$O ZS+ !>A"N+!C&ZA#W<X%(N;IFX(K<2WX
M/65!P_>V51HO ?@J8R;JG\2BH6_4;8G_[-V=0J>HACL$K5BIFX0&?A#'X9K+
MQ(_^HLOF-WK,"B]A%,RF3(.P%8DV!@;5EH8@JP2J%.;-F_9LU V M1?'!Z&T
M04'\)L!OYW3U&)2I<;Y[S.DAJ!T=)'#3_^>U,@ZG^'UN/0!EV:P;B/K)Q.AZ
MP5G#FX:[>1T!66F FX^[@&G60H(S%8=4'>OF23O]EB%MTK0;J'\(FB2$37@<
MKUA^4T;:TEJ1W!&R]59X39 +O#6"2 3G%6"[A#/%+39>1KEI]VXXW_*(!C2A
M;/Y)K;@%]2-;EDV9'8%<8X)71;@@7*6&Q.^C/!3ZSO"VU7*9W$9]NV%[+8B>
M#Z*P2!\'TU\1$%=W=_8+ASJ%CC"V,,7W1;I@O4\5"6]5!LIU("L$:25GT-LV
M40;^F4Y0T;^0<D6$^P 8=%[&&%0;- _#3CSB2%1HMS486;E6YZ,E1[53TLB6
MX_*&!"NUGMH,1[,I32+K>QR[>5TM;:H,</-QIV6-40MK49.+@U*'5-Y]3=-*
MOULKF@9-NX$Z%;[^ONWM)IYQZR7XDZ2.$#6WS@T'7> T""&1F2M#)NU,90N-
MEI&T[1;GNGFV#A;*+6GR1+<YM^/KI]$(KX[!N([NZF%?2XL*.$]TM]>W\9IJ
MV3S&YWMG,1%S-34?!7](%FHQLO19PV\S5DAT^@E?O2V^-]3],[X:6236\P_&
MBD*058*\%-)G?"W:,'S(9^NEO.-2;>G?.Y'OHMEO7U![_@-02P,$%     @
M@H)-5B09M(6U!   ="H  !4   !C=&MB+3(P,C,P,C$S7W!R92YX;6S5FEV/
MXC84AN]7VO_@IC>MU! ",],=-,R*,C,KU/D2P[95;U8F.8 UCHUL,\"_[W'
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MB/,*MB0-0I\4<UGT70I8</"_/'I,J'6TW]K>VEL41KUE-_8!_&U8#&%R*9+
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MBQI?@GJ3W3'@4N)M3U5@>1P^-/;?\",>>&43&8\+@2KG^ []&8=H4&/S =7
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MO'HO4+WZRSCUL'A3 K)EP%L&Q#( GEJD2-)%J,1;L0DK=I8PAZ!HU5;MP^<
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MZC:FG,7EY8%"\#:D<$]3'$LE"#W,? YI*YDG'.^8H/&6(G8N,R#'&Q;TAG)
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M0Q*XZU=Z"&\V&QL%_N=R,]3:O\.\_J80RM]I?L0@_YWV_P502P$"% ,4
M" ""@DU6L).I0CT#  ! "P  $0              @ $     8W1K8BTR,#(S
M,#(Q,RYX<V102P$"% ,4    " ""@DU6$&+.T%P&  "^0P  %0
M    @ %L P  8W1K8BTR,#(S,#(Q,U]L86(N>&UL4$L! A0#%     @ @H)-
M5B09M(6U!   ="H  !4              ( !^PD  &-T:V(M,C R,S R,3-?
M<')E+GAM;%!+ 0(4 Q0    ( (*"35:+D821TA8  %6$   .
M  "  >,.  !D-#0V.38S9#AK+FAT;5!+ 0(4 Q0    ( (*"35;/:"##F1<
M *Y=   1              "  >$E  !D-#0V.38S9&5X.3DQ+FAT;5!+!08
1    !0 % $ !  "I/0     !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
